Childhood and adolescent influenza vaccination in Europe: A review of current policies and recommendations for the future

Expert Review of Vaccines
Alistair McGuireSam Keeping

Abstract

Children and adolescents experience some of the highest rates of influenza infection and the subsequent burden on both infected children and their parents/carers is substantial. Vaccinating children and adolescents against seasonal influenza has the potential to reduce the burden of disease in both vaccinated and unvaccinated individuals due to the pivotal role that younger age groups play in the transmission of infection. While countries such as the USA, Canada and the UK have consequently recommended the universal vaccination of children, the vast majority of European countries have not yet extended their vaccination policies to this age group. This review examines the rationale for childhood and adolescent vaccination against seasonal influenza and reviews current vaccination policies in Europe. We discuss key policy considerations for European countries that must be considered when extending vaccination programmes to younger age groups alongside recommendations for European policy makers based on our findings.

References

Jul 1, 1970·The Journal of Infectious Diseases·A S MontoT Francis
Mar 18, 2000·The Journal of Infectious Diseases·L SimonsenN J Cox
Mar 22, 2001·The New England Journal of Medicine·T A ReichertM Tashiro
Apr 6, 2002·BMJ : British Medical Journal·Caroline L Trotter, W John Edmunds
Aug 16, 2002·Occupational Medicine·F W O'Reilly, A B Stevens
Feb 1, 2003·The Lancet Infectious Diseases·Heinz J SchmittHeikki Peltola
Mar 19, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Manabu AkazawaA David Paltiel
Sep 21, 2004·The Journal of Infectious Diseases·Terho HeikkinenTaina Juven
May 14, 2005·BMJ : British Medical Journal·Ravindra K GuptaEithne MacMahon
Jun 3, 2005·The Pediatric Infectious Disease Journal·Sharon G Humiston, Susan L Rosenthal
May 9, 2006·Vaccine·Heini SaloTerho Heikkinen
Jul 11, 2006·The New England Journal of Medicine·Katherine A PoehlingUNKNOWN New Vaccine Surveillance Network
Dec 15, 2006·The New England Journal of Medicine·James C KingKathleen Neuzil
Jul 20, 2007·BMJ : British Medical Journal·Ben Goldacre
Mar 28, 2008·PLoS Medicine·Joël MossongW John Edmunds
Apr 1, 2008·The American Journal of Medicine·Michael B RothbergRichard B Brown
May 20, 2008·Travel Medicine and Infectious Disease·Stephen Toovey
May 19, 2009·The Journal of Infection·Patricia R BlankThomas D Szucs
May 30, 2009·The Pediatric Infectious Disease Journal·Carrie ReedLyn Finelli
Oct 27, 2009·British Medical Bulletin·M J Keeling, L Danon
Dec 24, 2009·PLoS Currents·Shweta BansalLauren Ancel Meyers
Mar 11, 2010·JAMA : the Journal of the American Medical Association·Mark LoebStephen D Walter
Oct 12, 2010·The Pediatric Infectious Disease Journal·Stan L BlockChristopher S Ambrose
Nov 19, 2010·The New England Journal of Medicine·Linda C Lambert, Anthony S Fauci
Nov 26, 2010·The Lancet Infectious Diseases·Santtu HeinonenTerho Heikkinen
Aug 9, 2011·Vaccine·Pieter L A Fraaij, Terho Heikkinen
Oct 13, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Erin Walkinshaw
Oct 15, 2011·The New England Journal of Medicine·Timo VesikariRalf Clemens
Oct 29, 2011·The Lancet Infectious Diseases·Michael T OsterholmEdward A Belongia
Oct 29, 2011·Vaccine·Spring Chenoa Cooper RobbinsS Rachel Skinner
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Catherine Weil Olivier
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Christopher S Ambrose, Myron J Levin
Feb 14, 2012·Human Vaccines & Immunotherapeutics·Patricia BlankThomas D Szucs
Jul 14, 2012·PharmacoEconomics·Anthony T NewallPhilippe Beutels
Sep 19, 2012·Influenza and Other Respiratory Viruses·Ashley FowlkesLyn Finelli
Nov 14, 2012·BMC Public Health·Evgeniya N AntonovaNicola Principi
Jan 30, 2013·Human Vaccines & Immunotherapeutics·Mark JitPhilippe Beutels
Jul 17, 2013·The Pediatric Infectious Disease Journal·Terho HeikkinenAdam Finn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.